Skip to main content

Peer Review reports

From: Long-term reductions in disease impact in patients with chronic migraine following preventive treatment with eptinezumab

Original Submission
24 Mar 2022 Submitted Original manuscript
8 Apr 2022 Reviewed Reviewer Report
13 Jun 2022 Reviewed Reviewer Report - Takao Takeshima
22 Jun 2022 Author responded Author comments - Roger Cady
Resubmission - Version 2
22 Jun 2022 Submitted Manuscript version 2
23 Jun 2022 Author responded Author comments - Roger Cady
Resubmission - Version 3
23 Jun 2022 Submitted Manuscript version 3
25 Jun 2022 Reviewed Reviewer Report
25 Jun 2022 Reviewed Reviewer Report - Takao Takeshima
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
27 Jun 2022 Editorially accepted
8 Jul 2022 Article published 10.1186/s12883-022-02774-3

You can find further information about peer review here.

Back to article page